Skip to the content

REVOLUTIONIZING TREATMENT DECISIONS

Home
Solutions
Resources
About
Careers

Home
Solutions
Resources
About
Careers

Our resources

Peer-Reviewed Papers

All
Best Practices
Methodological papers
Trial Analysis
Trial Designs

Correcting the bias of the net benefit estimator due to right-censored observations

Methodological papers

Correcting the bias of the net benefit estimator due to right-censored observations

Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints

Methodological papers

Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma

The Benefit-Risk Balance of Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma

Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit

Restricted Net Treatment Benefit in oncology

Methodological papers

Restricted Net Treatment Benefit in oncology

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)

How an Innovative Statistical Methodology Enables More Patient-Centric Design and Analysis of Clinical Trials

« Previous

1
2
3

Want to invest in a more holistic understanding
of net treatment benefit?

Get in touch

SOLUTIONS

Patient Centric Clinical Trial Design
Inform Dose Optimization
Benefit Risk Assessment

ABOUT

About One2Treat
One2Treat’s Team
Contact

RESOURCES

Learn more about Net Treatment Benefit
Case studies
Regulatory submissions
PRs, podcasts & webinars
Scientific papers

Copyright © 2026 One2Treat
Privacy Policy

Manage Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}